| Literature DB >> 25920529 |
Claudia Robles1,2, Delphine Casabonne2,3, Yolanda Benavente2,3, Laura Costas2,3, Eva Gonzalez-Barca4, Marta Aymerich5, Elias Campo5, Adonina Tardon3,6, José J Jiménez-Moleón3,7,8, Gemma Castaño-Vinyals1,3,9,10, Trinidad Dierssen-Sotos3,11, Angelika Michel12, Lena Kranz13, Nuria Aragonés3,14,15, Marina Pollan3,14,15, Manolis Kogevinas16,3,9,1,10, Michael Pawlita13, Silvia de Sanjose2,3.
Abstract
Merkel cell polyomavirus (MCPyV) has been suspected to cause chronic lymphocytic leukaemia (CLL) but previous data are inconsistent. We measured seroreactivities of nine polyomaviruses (MCPyV, BKPyV, JCPyV, LPyV, KIPyV, WUPyV, HPyV-6, HPyV-7 and TSPyV) in 359 CLL cases and 370 controls using bead-based multiplex serology technology. We additionally tested two herpesviruses (HSV-1 and CMV). Associations between disease and viral seroreactivities were assessed using logistic regression. All human viruses showed high seroprevalences (69-99%) against structural proteins in controls but significantly lower viral seroprevalences in cases (58-94%; OR range = 0.21-0.70, P value < 0.05), except for MCPyV (OR = 0.79, 95% CI = 0.54-1.16). Lower seroreactivity levels were observed among CLL subjects, with significant differences already observed at early stages of disease, unrelated to treatment status. Seroreactivities against polyomavirus related oncoproteins were almost null. Our data suggest no association for MCPyV polyomavirus with CLL development and an unlikely association for other polyomaviruses tested.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25920529 DOI: 10.1099/vir.0.000167
Source DB: PubMed Journal: J Gen Virol ISSN: 0022-1317 Impact factor: 3.891